Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-27

Clinical Trial Update: Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy

View source ↗

Summary

A clinical trial update from Endeavor Health evaluating how an inherited risk assessment performs in predicting prostate cancer from prostate biopsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Endeavor Health | Conditions: Prostate Cancer | Status: RECRUITING